Scheme Name | 1Y(%) | 2Y(%) | 3Y(%) | 5Y(%) | 10Y(%) |
---|---|---|---|---|---|
Quant Healthcare Fund - Growth Option - Regular Plan | 33.84 | 0 | 0 | 0 | 0 |
HDFC Pharma and Healthcare Fund - Growth Option | 51.93 | 0 | 0 | 0 | 0 |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option | 49.14 | 42.19 | 25.88 | 30.29 | 0 |
LIC MF Healthcare Fund-Regular Plan-Growth | 46.79 | 33.15 | 18.73 | 23.24 | 0 |
UTI Healthcare Fund - Regular Plan - Growth Option | 45.36 | 38.84 | 22.11 | 27.61 | 13.24 |
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 44.94 | 34.91 | 20.91 | 0 | 0 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | 44.04 | 38.4 | 25.19 | 29.28 | 13.92 |
DSP Healthcare Fund - Regular Plan - Growth | 42.48 | 36.36 | 23.06 | 30.74 | 0 |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 42.34 | 36.2 | 22.77 | 27.39 | 0 |
Mirae Asset Healthcare Fund -Regular Growth | 40.87 | 34.25 | 19.81 | 28.75 | 0 |
Based On | Quant Healthcare Fund - Growth Option - Regular Plan | NIFTY 50 TRI | Equity: Sectoral-Pharma and Healthcare |
---|---|---|---|
CAGR since inception | 35.34% | 13.95% | 23.85% |
1 Year | 33.84% | 12.84% | 42.68% |
3 Year | 0.00% | 13.73% | 21.89% |
5 Year | 0.00% | 15.28% | 27.69% |
10 Year | 0.00% | 12.46% | 14.22% |
Nav / Index Value as on2024-12-22 | 434.26% | 0.00% | 0.00% |
Sector | Allocation |
---|---|
Others | -0.41 |
Debt | 1.12 |
Cash & Cash Equivalents | 0.32 |
Equity | 98.95 |
Company | Holding |
---|---|
ASTER DM HEALTHCARE LIMITED | 8.02 |
RPG LIFE SCIENCES LIMITED | 7.72 |
HFCL LIMITED | 7.02 |
PFIZER LIMITED | 6.93 |
RELIANCE INDUSTRIES LIMITED | 6.91 |
AUROBINDO PHARMA LIMITED | 6.24 |
SEQUENT SCIENTIFIC LIMITED | 6.23 |
ZYDUS LIFESCIENCES LIMITED | 6.19 |
GLENMARK LIFE SCIENCES LIMITED | 6.07 |
IPCA LABORATORIES LIMITED | 6 |
To calculate the Quant Mutual Fund :
1. Visit https://www.swarajfinpro.com/Calculator-SIP
2. Put the monthly SIP amount.
3. Put the monthly expected returns.
4. Write down the time period of investment.